RedHill’s Global Licensing Agreement with Hyloris

Haynes Boone represented RedHill in the transaction. RedHill Biopharma Ltd. (NASDAQ: RDHL) announced an exclusive worldwide development and commercialization licensing agreement, excluding North America, for its…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here